Long-Term Effect of Interferon Plus Ribavirin on Hepatitis B Surface Antigen Seroclearance in Patients Dually Infected with Hepatitis B and C Viruses

BACKGROUND: Interferon-α/ribavirin combination therapy might promote hepatitis B surface antigen (HBsAg) seroclearance in patients dually infected with hepatitis B and C viruses (HBV/HCV), but the long-term effect remains unclear. We aimed to investigate the rate of and the factors associated with H...

Descripción completa

Detalles Bibliográficos
Autores principales: Yeh, Ming-Lun, Hung, Chao-Hung, Huang, Jee-Fu, Liu, Chun-Jen, Lee, Chuan-Mo, Dai, Chia-Yen, Wang, Jing-Houng, Lin, Zu-Yau, Lu, Sheng-Nan, Hu, Tsung-Hui, Yu, Ming-Lung, Kao, Jia-Horng, Chuang, Wan-Long, Chen, Pei-Jer, Chen, Ding-Shinn
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2011
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3113900/
https://www.ncbi.nlm.nih.gov/pubmed/21695152
http://dx.doi.org/10.1371/journal.pone.0020752

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3113900/
https://www.ncbi.nlm.nih.gov/pubmed/21695152
http://dx.doi.org/10.1371/journal.pone.0020752

Ejemplares similares